FLX BIO Trademark

Trademark Overview

On Thursday, March 17, 2016, a trademark application was filed for FLX BIO with the United States Patent and Trademark Office. The USPTO has given the FLX BIO trademark a serial number of 86943860. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, July 12, 2024. This trademark is owned by FLX Bio, Inc.. The FLX BIO trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

The discovery, research, and development of therapeutics for the treatment and/or prevention of cancer-related and/or immune-related disorders; research and development in the pharmaceutical and biotechnology fields; research and development of pharmaceuticals and therapeutics for the treatment of immuno-oncology - related disorders
flx bio

General Information

Serial Number86943860
Word MarkFLX BIO
Filing DateThursday, March 17, 2016
Status710 - CANCELLED - SECTION 8
Status DateFriday, July 12, 2024
Registration Number5365577
Registration DateTuesday, December 26, 2017
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, October 4, 2016

Trademark Statements

Description of MarkThe mark consists of the letters "FLX" and "BIO" with a double curved line between them.
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesThe discovery, research, and development of therapeutics for the treatment and/or prevention of cancer-related and/or immune-related disorders; research and development in the pharmaceutical and biotechnology fields; research and development of pharmaceuticals and therapeutics for the treatment of immuno-oncology - related disorders

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, July 12, 2024
Primary Code042
First Use Anywhere DateThursday, July 23, 2015
First Use In Commerce DateThursday, July 23, 2015

Trademark Owner History

Party NameRAPT THERAPEUTICS, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressSOUTH SAN FRANCISCO, CA 94080
Party NameFLX Bio, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameFLX Bio, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameFLX Bio, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events

Event DateEvent Description
Wednesday, June 29, 2016NON-FINAL ACTION E-MAILED
Wednesday, June 29, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, August 25, 2016ASSIGNED TO LIE
Monday, March 21, 2016NEW APPLICATION ENTERED
Wednesday, March 23, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 24, 2016NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, June 28, 2016ASSIGNED TO EXAMINER
Wednesday, June 29, 2016NON-FINAL ACTION WRITTEN
Friday, August 19, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 25, 2017SOU TEAS EXTENSION RECEIVED
Thursday, August 25, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 25, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, August 26, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, August 27, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, September 14, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 4, 2016PUBLISHED FOR OPPOSITION
Tuesday, October 4, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 29, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, May 25, 2017TEAS STATEMENT OF USE RECEIVED
Friday, June 2, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, June 23, 2017STATEMENT OF USE PROCESSING COMPLETE
Thursday, May 25, 2017SOU EXTENSION 1 FILED
Thursday, May 25, 2017USE AMENDMENT FILED
Friday, June 23, 2017SOU EXTENSION 1 GRANTED
Friday, November 17, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, June 24, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 30, 2017SU - NON-FINAL ACTION - WRITTEN
Wednesday, August 30, 2017NON-FINAL ACTION E-MAILED
Wednesday, August 30, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, November 21, 2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, December 26, 2017REGISTERED-PRINCIPAL REGISTER
Wednesday, July 24, 2019AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, December 26, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, July 12, 2024CANCELLED SEC. 8 (6-YR)
Monday, November 20, 2017ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, November 17, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, November 18, 2017TEAS/EMAIL CORRESPONDENCE ENTERED

Related Keywords

development related research disorders treatment therapeutics fields immuno oncology biotechnology